Fundraising Fox

Larimar Therapeutics

NASDAQ: LRMR

Bala Cynwyd, US · Delaware corporation

Biotech

Founders & leadership

MC
Michael CelanoChief Financial Officer
CB
Carole Ben Maimon, MDPresident and CEO
TO
Thomas O. DanielNamed on SEC filing
TH
Thomas HamiltonNamed on SEC filing
FE
Frank E. ThomasNamed on SEC filing
PB
Peter BarrettNamed on SEC filing
JT
Joseph TruittNamed on SEC filing

Board

JL
Jonathan LeffBoard director

Reported raises · per SEC filings

Form D private placements

$162.1M disclosed across 2 rounds · 2020

▶$82.1MraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan LeffDirector
  • Thomas O. DanielDirector
  • Thomas HamiltonDirector
  • Michael CelanoExecutive Officer
  • Frank E. ThomasDirector
  • Carole Ben Maimon, MDExecutive Officer, Director
  • Peter BarrettDirector
  • Joseph TruittDirector
Offering amount
$82.1M
Amount sold
$82.1M
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$80MraisedJun 2020 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan LeffDirector
  • Thomas O. DanielDirector
  • Peter BarrettDirector
  • Joseph TruittDirector
  • Frank E. ThomasDirector
  • Thomas HamiltonDirector
  • Michael CelanoExecutive Officer
  • Carole Ben Maimon, MDExecutive Officer, Director
Offering amount
$80M
Amount sold
$80M
Sales commissions
$4.8M
Placement agents
MTS Partners
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Larimar Therapeutics raised?
Larimar Therapeutics has disclosed $162.1M raised across 2 rounds.
Where is Larimar Therapeutics headquartered?
Larimar Therapeutics is headquartered in Bala Cynwyd, US.